Insider · CIK 0001326530
Cheryl R Blanchard
ceopresidentofficerdirector
Files at ANIK (Anika Therapeutics, Inc.), VIGL (Vigil Neuroscience, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Common Stock | -5,000 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -24,761 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -24,984 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -36,690 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -18,068 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -13,928 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -5,017 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -12,155 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -6,432 | - | - | 0 | Aug 5, 2025 |
| May 22, 2025 | VIGL Vigil Neuroscience, Inc. | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 5,000 | May 23, 2025 |
| Mar 17, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Common Stock | +25,132 | $0.00 | $0 | 209,472 | Mar 18, 2025 |
| Mar 17, 2025 | ANIK Anika Therapeutics, Inc. | FTax withholding Common Stock | -12,152 | $15.91 | $193k | 197,320 | Mar 18, 2025 |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | AGrant or award Restricted Stock Unitderivative | +73,559 | $0.00 | $0 | 73,559 | Mar 18, 2025 |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | AGrant or award Restricted Stock Unitderivative | +71,403 | $0.00 | $0 | 71,403 | Mar 18, 2025 |
| Mar 17, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Restricted Stock Unitderivative | -25,132 | $0.00 | $0 | 50,263 | Mar 18, 2025 |
| Mar 11, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Common Stock | +30,060 | $0.00 | $0 | 197,015 | Mar 13, 2025 |
| Mar 11, 2025 | ANIK Anika Therapeutics, Inc. | FTax withholding Common Stock | -12,675 | $16.79 | $213k | 184,340 | Mar 13, 2025 |
| Mar 11, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Restricted Stock Unitderivative | -30,060 | $0.00 | $0 | 0 | Mar 13, 2025 |
| Mar 10, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Common Stock | +20,002 | $0.00 | $0 | 172,826 | Mar 11, 2025 |
| Mar 10, 2025 | ANIK Anika Therapeutics, Inc. | FTax withholding Common Stock | -5,871 | $16.62 | $98k | 166,955 | Mar 11, 2025 |
| Mar 10, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Restricted Stock Unitderivative | -20,002 | $0.00 | $0 | 20,001 | Mar 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.